News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Frances K. Heller Joins Adimab LLC. Board of Directors


4/20/2011 8:31:09 AM

HANOVER, N.H.--(BUSINESS WIRE)--Adimab LLC, a leader in the discovery of fully human antibodies, today announced that Frances K. Heller has been appointed to its Board of Directors. Ms. Heller is the Executive Vice President of Business Development of Exelixis, Inc. (Nasdaq: EXEL) and is an acknowledged life sciences business development leader, having led or participated in nearly 100 transactions over the course of her career.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES